| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Ketogenesis and ketolysis 0.8873666527772599 2.426424016567042 0.0152484430173331 0.999909642180602 1.0 6 P53985 1 |
| Disorders of folate metabolism and transport 0.7942943712365675 1.9954788295636476 0.0459906808698225 0.9999999999995935 1.0 8 P49914,P04818,P00374 3 |
| Lung fibrosis 0.7633061742338321 1.9094979551338904 0.0561978852707625 0.9999999999999994 1.0 6 P09601 1 |
| Methionine de novo and salvage pathway 0.7574507940152998 1.7940550348784672 0.0728043850385438 1.0 1.0 10 Q9BV20,P52788,Q13126,Q9BV57 4 |
| Ethanol effects on histone modifications 0.7344931654957264 1.715960073669064 0.0861693502847931 1.0 1.0 9 Q9H9T3,P04818 2 |
| Hostpathogen interaction of human coronaviruses autophagy 0.7495462271871691 1.6999258104777666 0.0891448813093565 1.0 1.0 5 O95352 1 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.7156690097351763 1.557611826772479 0.1193252934118611 1.0 1.0 5 P09601 1 |
| Development of ureteric collection system 0.7147351003265684 1.5536722767980726 0.1202626091992371 1.0 1.0 5 Q13418,Q12948 2 |
| Mitochondrial long chain fatty acid betaoxidation 0.6895183406569233 1.4349369397884784 0.1513050680955419 1.0 1.0 13 P11310,P49748 2 |
| Ddx1 as a regulatory component of the drosha microprocessor 0.685041243154055 1.4280627679806726 0.1532737927887588 1.0 1.0 5 P49959,Q8WYQ5 2 |
| Histone modifications 0.6688139288312842 1.4276581733361342 0.1533902706917147 1.0 1.0 9 Q8WTS6,Q9H7B4,Q01105,Q9H9B1 4 |
| Camkk2 pathway 0.6770002338007559 1.399497893319417 0.1616637296422733 1.0 1.0 12 P09601 1 |
| 15q112 copy number variation syndrome 0.7046152155153593 1.3737074038712973 0.1695325374289096 1.0 1.0 4 Q96CW5 1 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.6359243249873505 1.3533888494092463 0.1759314378243597 1.0 1.0 6 P04792 1 |
| Cytosine methylation 0.6635507464716954 1.3368591183095269 0.1812686275173831 1.0 1.0 5 P26358,O95983,P48735 3 |
| 1q211 copy number variation syndrome 0.6345866180981519 1.322982730750305 0.1858411208387105 1.0 1.0 7 Q86WJ1,Q9NPH0 2 |
| Biomarkers for pyrimidine metabolism disorders 0.6417226847187621 1.3078553684835132 0.1909223700921827 1.0 1.0 9 Q02127 1 |
| Metastatic brain tumor 0.7651467832604608 1.2751444603684272 0.2022581151690219 1.0 1.0 3 P60953,Q00534 2 |
| Cellular proteostasis 0.6705180001327542 1.2347095497041494 0.2169386204888179 1.0 1.0 4 Q99471 1 |
| Glutathione metabolism 0.6056518268356892 1.219326946086311 0.2227201251870896 1.0 1.0 6 P00390,P48637,P28161 3 |
| Pyrimidine metabolism and related diseases 0.6171088950089574 1.198991529690197 0.2305312392021954 1.0 1.0 9 Q02127 1 |
| Pentose phosphate pathway in senescent cells 0.6221816053401801 1.161275820214557 0.2455297494430448 1.0 1.0 5 O95336,P29401,P04637 3 |
| Mirna biogenesis 0.6516331967362589 1.157890169290125 0.2469088598183364 1.0 1.0 4 Q9HAV4 1 |
| Exrna mechanism of action and biogenesis 0.7340938941876821 1.1575001395122202 0.2470680823356881 1.0 1.0 3 Q9HAV4 1 |
| Genes controlling nephrogenesis 0.5963404691807266 1.1537797782028845 0.2485904667103482 1.0 1.0 7 Q12948,P11047,Q9Y5K6,O94813,Q13418 5 |
| Interactions between loxl4 and oxidative stress pathway 0.7322149981773698 1.1504013179641042 0.249978617567061 1.0 1.0 3 Q16543 1 |
| Oxidative stress response 0.593755617472041 1.1188182082626177 0.2632177021181394 1.0 1.0 8 P09601 1 |
| Gdnfret signaling axis 0.6393892875645351 1.10823658734088 0.267759653569759 1.0 1.0 4 Q12948 1 |
| Interactome of polycomb repressive complex 2 prc2 0.6049351307755488 1.0883672135615168 0.2764330290872232 1.0 1.0 5 Q9Y2W1 1 |
| Foxa2 pathway 0.6141830677913027 1.0066235178105143 0.3141157284732441 1.0 1.0 4 O15439,Q13085,P28161 3 |
| Vegfavegfr2 signaling pathway 0.3169740108204802 0.9869539315176882 0.3236652233710382 1.0 1.0 170 O00231,P04792,P11940,P17655,P61254,Q9NSD9,P78344,Q04637,P49841,Q14241,P55196,Q6Y7W6,P18085,Q9Y305,Q8N3C0,Q9Y613,Q9UL54,O75347,Q96PU8,P19338,P51116,P48735,Q12965,P60953,Q01844,Q01105,P04083,Q4VCS5,P18206,O14964,P53680,Q96CT7,O15372,P09429,Q99832,Q9H2U1,Q9HCE1,P24666,Q9NQ29,Q13045,Q16539,Q13464,Q00610,P62753,P46108,Q14157,P42566,P07814,P00491,O15371,O00763,Q9UDY4 52 |
| Neuroinflammation 0.5803445342346163 0.9851051950979142 0.3245724018061926 1.0 1.0 5 Q8N9N2,Q16539,P00403 3 |
| Serine metabolism 0.5495606002670579 0.972385480770316 0.3308588123350378 1.0 1.0 6 P04818 1 |
| Praderwilli and angelman syndrome 0.5550280216445483 0.9493576916654438 0.342438720687521 1.0 1.0 8 Q00534,Q15154,Q9UIS9 3 |
| Photodynamic therapyinduced hif1 survival signaling 0.5666725377683004 0.9348550114142272 0.3498630247432133 1.0 1.0 11 P53985 1 |
| Fatty acid betaoxidation 0.5961568134801317 0.902807137377094 0.3666282624440531 1.0 1.0 20 P11310,P49748 2 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.542938610144592 0.8971340954653308 0.3696473670627185 1.0 1.0 8 Q13418,P49770 2 |
| Pi3kaktmtor vitd3 signaling 0.5573219919280443 0.8895809747048957 0.3736909256724772 1.0 1.0 5 P49841,P08559 2 |
| Smc1smc3 role in dna damage cornelia de lange syndrome 0.5388033249123427 0.8793717054021958 0.379199768382511 1.0 1.0 8 Q92878,P49959,O60216,Q14683 4 |
| Intraflagellar transport proteins binding to dynein 0.5387569908324121 0.8791730036330792 0.3793074796031828 1.0 1.0 8 Q96FJ2,Q9Y6G9,Q13409 3 |
| Proximal tubule transport 0.5430206441353072 0.8541734407559594 0.393008896751251 1.0 1.0 10 O15439,Q9Y5K8,P36543,P38606 4 |
| Onecarbon metabolism 0.5627833180061803 0.8243127711883418 0.4097618638371982 1.0 1.0 16 P49914,P04818,P00374 3 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.5183850620681576 0.8147793948700358 0.4151985975000034 1.0 1.0 7 Q8WX92,Q8IXH7 2 |
| Cardiac progenitor differentiation 0.8323446768654369 0.8122838559905494 0.4166287719022694 1.0 1.0 2 Q16539 1 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.5580666790680398 0.7856723853298144 0.4320594453142552 1.0 1.0 4 P49841 1 |
| Vitamin b12 disorders 0.624921923797624 0.7549147441308475 0.4503001385013658 1.0 1.0 3 P22033,Q99707 2 |
| Pentose phosphate metabolism 0.5194947252658916 0.7364622337445189 0.4614494429331994 1.0 1.0 5 O95336,P29401,P37837 3 |
| Dna mismatch repair 0.5556050583097141 0.7318547461846451 0.4642572298696832 1.0 1.0 20 Q9UQ84,P56282,P15927 3 |
| Urea cycle and metabolism of amino groups 0.5014523315900263 0.7011689858114099 0.4831975623881155 1.0 1.0 9 P78540 1 |
| Purine metabolism 0.5041677549998075 0.6921318005305214 0.4888545627139913 1.0 1.0 10 P31939,P00813,P30520,P00491 4 |
| Interleukin1 induced activation of nfkb 0.7945675928816709 0.6903289056603177 0.4899873741172813 1.0 1.0 2 P61088 1 |
| Cerebral organic acidurias including diseases 0.5065281363813331 0.6854904417252551 0.493034490135517 1.0 1.0 5 P48735 1 |
| Autophagy 0.4913822489896465 0.6807817150530694 0.4960096216058245 1.0 1.0 8 Q14457,O95352 2 |
| Neurodegeneration with brain iron accumulation nbia subtypes pathway 0.5142253104050208 0.6763594956498757 0.4988124270838054 1.0 1.0 13 O95352,Q13057 2 |
| Ferroptosis 0.5462909916941858 0.6542937980150095 0.5129225408186926 1.0 1.0 23 P09601,Q9NZZ3,P04792 3 |
| Pregnane x receptor pathway 0.4951557512787241 0.6415925219302637 0.5211377896905882 1.0 1.0 5 O15439 1 |
| Nrf2 pathway 0.531364994225187 0.6341377790914495 0.5259909094684241 1.0 1.0 20 P09601,P30043,O15439,Q9H2J7,Q99735 5 |
| Glycogen synthesis and degradation 0.5191021672470449 0.6294263329622162 0.5290699828549057 1.0 1.0 17 P46976,Q15257,Q16537,P36871,P30154,P49841 6 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.4868265028515376 0.6099785429194816 0.5418760214591551 1.0 1.0 5 P02545,P49354,Q03252 3 |
| Atr signaling 0.5072285802146291 0.5969071518877004 0.5505693720788578 1.0 1.0 4 O14757,Q13535 2 |
| Sting pathway in kawasakilike disease and covid19 0.5762023735165496 0.588040059148896 0.5565054047744873 1.0 1.0 3 Q86UT6,O15111 2 |
| Supression of hmgb1 mediated inflammation by thbd 0.5762023735165496 0.588040059148896 0.5565054047744873 1.0 1.0 3 P09429,O15111 2 |
| Ppar signaling pathway 0.4996471285102461 0.5544008971297502 0.5793045122580092 1.0 1.0 17 P11310 1 |
| Mir517 relationship with arcn1 and usp1 0.747424289728376 0.5470794053150411 0.5843241804848589 1.0 1.0 2 O94782 1 |
| Gammaglutamyl cycle for the biosynthesis and degradation of glutathione including diseases 0.5546533416614589 0.5185818692061133 0.6040523552224111 1.0 1.0 3 P48637,O75223 2 |
| Aryl hydrocarbon receptor pathway wp2586 0.4420624319851235 0.4895229869826872 0.6244714844862937 1.0 1.0 8 O00170 1 |
| Purine metabolism and related disorders 0.4688740045624157 0.4709683809423795 0.637663314701495 1.0 1.0 15 Q06203,P00813,P31939,P00491,P30520,P22102 6 |
| Mirnas involved in dna damage response 0.5315185883142014 0.4477887623262994 0.6543056544124244 1.0 1.0 3 Q00534 1 |
| 15q133 copy number variation syndrome 0.5297014029185132 0.4424123255884984 0.6581908614455703 1.0 1.0 3 Q9BXW9 1 |
| Tp53 network 0.7059007180767989 0.4317648688971847 0.6659123152312221 1.0 1.0 2 P04637 1 |
| Prostaglandin synthesis and regulation 0.4192552826019355 0.4261581440984924 0.6699926144584507 1.0 1.0 7 P04083 1 |
| Hereditary leiomyomatosis and renal cell carcinoma pathway 0.4249407611129353 0.4116477029161508 0.6805976618415022 1.0 1.0 9 P62753,Q13618,P08559,P04637,O00763,P11177 6 |
| Aryl hydrocarbon receptor pathway wp2873 0.409264971667455 0.4094037495985038 0.6822433884125083 1.0 1.0 6 O00170 1 |
| Translation factors 0.5093109231273653 0.4082096102632906 0.6831197932525921 1.0 1.0 36 O43432,Q15056,O75153,O00303,P29692,P11940,O15372,O60841,P23588,Q04637,Q14232,O15371,P19525,P49770,O75822,P60228 16 |
| Deregulation of rab and rab effector genes in bladder cancer 0.6946612550733646 0.4026542051212337 0.6872026274774363 1.0 1.0 2 Q8IWJ2 1 |
| Mitochondrial complex ii assembly 0.6890415235716473 0.3884674602028879 0.6976701299965353 1.0 1.0 2 P21912 1 |
| Folate metabolism 0.4401322224402538 0.3737529232031084 0.708588147032587 1.0 1.0 15 P49914,Q8WTV0 2 |
| Tyrobp causal network in microglia 0.4174924025435069 0.3703216147583735 0.7111428705849758 1.0 1.0 5 O15439 1 |
| Constitutive androstane receptor pathway 0.3885258490756063 0.3411012514616674 0.7330273591365295 1.0 1.0 6 Q15257,Q14683 2 |
| Sudden infant death syndrome sids susceptibility pathways 0.4633450862826418 0.3147717144164313 0.7529349894475534 1.0 1.0 28 P11310,Q04917,Q9UIS9 3 |
| Complement and coagulation cascades 0.6578207930065515 0.3144340094723557 0.7531914291940125 1.0 1.0 2 Q00610 1 |
| Tca cycle in senescence 0.3795138512267257 0.3132769153290817 0.7540702869534837 1.0 1.0 6 P40925,P08559 2 |
| Proteasome degradation 0.4854889963892243 0.3115205235560089 0.755404943015392 1.0 1.0 42 Q9UNM6,O00231,P49721,O43242,P60900,Q9UL46,P28066,P28074,P04439,P46934,P62195,P20618,O75832,P28072,P22314,P28070 16 |
| Nanoparticle triggered autophagic cell death 0.3762192239827386 0.3034049590298514 0.7615812669270521 1.0 1.0 6 O95352 1 |
| Follicle stimulating hormone fsh signaling pathway 0.3727793570676672 0.2656257255136514 0.7905274710408077 1.0 1.0 8 Q16539,Q9UKG1,P49815 3 |
| Mammary gland development pathway involution stage 4 of 4 0.4558034930663457 0.2512835018267695 0.8015949296680753 1.0 1.0 3 P04637 1 |
| Nuclear receptors metapathway 0.4610229158120508 0.2371981006081473 0.8125031097702553 1.0 1.0 49 P11310,P09601,Q99735,Q15257,P30043,O15439,Q14914,Q9H2J7,O00170,Q16543,P23786 11 |
| Eicosanoid metabolism via lipooxygenases lox 0.3571462938835957 0.2368286423530513 0.8127897301811244 1.0 1.0 7 Q14914,O15254 2 |
| Type 2 papillary renal cell carcinoma 0.3485618320255647 0.2273169993207167 0.8201772555311659 1.0 1.0 6 Q92733 1 |
| Liver x receptor pathway 0.6137995629097667 0.2250974939256576 0.8219034305163395 1.0 1.0 2 O00767 1 |
| Mirna regulation of prostate cancer signaling pathways 0.3563346897402502 0.2228642251788763 0.8236411803116435 1.0 1.0 8 Q8NCF5,P49841 2 |
| Integrinmediated cell adhesion 0.4050490651144542 0.216213032149056 0.8288216956098968 1.0 1.0 21 P60953,P46108,P17655,Q9Y490,P18206,Q13418,Q15942,Q14155 8 |
| Cytosolic dnasensing pathway 0.3699786074475362 0.2033596286624903 0.8388539521265521 1.0 1.0 13 O15160 1 |
| Hedgehog signaling pathway wp4249 0.4280598298519125 0.1955518755335001 0.8449609306697154 1.0 1.0 3 P48729 1 |
| Exerciseinduced circadian regulation 0.3670699849559867 0.1881374205010517 0.8507689275140258 1.0 1.0 14 P78344,Q96PU8 2 |
| Hair follicle development organogenesis part 2 of 3 0.4175515302935627 0.1769629814342778 0.8595374671452769 1.0 1.0 3 P05556,P35222 2 |
| Urea cycle and related diseases 0.5841398688729256 0.175610051726393 0.8606003049451183 1.0 1.0 2 Q9Y619 1 |
| Dna irdamage and cellular response via atr 0.4293718221898736 0.1745037233458865 0.8614696048557067 1.0 1.0 43 Q9UQ84,Q13472,P53350,P15927,O94782,Q13535,Q96RL1,P23025,Q9HAW4,Q9BXW9 10 |
| Dna irdouble strand breaks and cellular response via atm 0.3998189681145225 0.169257388813303 0.8655941911402996 1.0 1.0 27 Q9UQ84,Q15554,Q13535,Q9BXW9 4 |
| Allograft rejection 0.3362925543603777 0.1677510956151794 0.8667790972187768 1.0 1.0 9 P04439 1 |
| Altered glycosylation of muc1 in tumor microenvironment 0.5760224789260006 0.1636054761731903 0.8700417334364374 1.0 1.0 2 O15111 1 |
| Canonical nfkb pathway 0.5760224789260006 0.1636054761731903 0.8700417334364374 1.0 1.0 2 O15111 1 |
| Photodynamic therapyinduced nfkb survival signaling 0.5760224789260006 0.1636054761731903 0.8700417334364374 1.0 1.0 2 O15111 1 |
| Imatinib and chronic myeloid leukemia 0.4066208619612705 0.1591174348227551 0.8735763522166509 1.0 1.0 3 P46087,Q13309 2 |
| Atm signaling in development and disease 0.3856960959090764 0.1581962014612729 0.8743021968602891 1.0 1.0 24 P04792,Q13535,Q15257 3 |
| Sarscov2 b117 variant antagonises innate immune activation 0.5679050889790758 0.1522605667893335 0.8789814253728911 1.0 1.0 2 O94826 1 |
| Notch signaling 0.3190315265845757 0.1515104858189389 0.8795730398366797 1.0 1.0 7 Q13363 1 |
| Homologous recombination 0.3148021441458836 0.1436395962794322 0.8857850715542013 1.0 1.0 7 Q92878,P49959,P28340 3 |
| 16p112 proximal deletion syndrome 0.3844069480551489 0.142487093454675 0.8866952732863946 1.0 1.0 27 Q9UL54,P49368,Q8TF05,Q9BW71 4 |
| Burn wound healing 0.3218747341583311 0.1404951637101013 0.8882687733931358 1.0 1.0 9 Q99439,P09429,P31949 3 |
| Fluoropyrimidine activity 0.3332319114226632 0.1259631030436663 0.8997611313893765 1.0 1.0 14 O15439,P04818,P00374 3 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.332446410350908 0.1247535295486534 0.9007186779303298 1.0 1.0 14 O00303,O15372,O15371,O75822,P60228 5 |
| Nucleotide excision repair 0.3688434068881943 0.122890960601702 0.9021934437633574 1.0 1.0 26 P56282,P15927,P23025 3 |
| Nanoparticlemediated activation of receptor signaling 0.2919455615211072 0.1130251064739225 0.9100106506621064 1.0 1.0 6 Q16539 1 |
| Dna repair pathways full network 0.3848387564906868 0.1089217053708346 0.913264590673156 1.0 1.0 57 P56282,Q9UQ84,Q9NRF9,P15927,O94782,Q13535,P23025,Q15554 8 |
| Arrhythmogenic right ventricular cardiomyopathy 0.3154357725970402 0.1057968122242025 0.9157435660727232 1.0 1.0 13 P02545,P14923,P15924,P12814 4 |
| Eicosanoid metabolism via cyclooxygenases cox 0.2898016302153698 0.1036233979171176 0.9174682187678892 1.0 1.0 7 Q14914,O15254 2 |
| Mitochondrial immune response to sarscov2 0.2961634293911381 0.1009446995992314 0.9195943591576664 1.0 1.0 9 Q86UT6,O94826,P35232,Q9BQ95 4 |
| Nucleotide excision repair in xeroderma pigmentosum 0.3664350411054868 0.0983068109419976 0.9216886700317553 1.0 1.0 35 P56282,Q9NRF9,P15927,P23025,Q13098 5 |
| Proteoglycan biosynthesis 0.29362166117295 0.0961435937576316 0.9234065288376492 1.0 1.0 4 O43909 1 |
| Vasopressinregulated water reabsorption 0.3210568725102757 0.0954898791920822 0.923925728761276 1.0 1.0 17 Q9UJW0,Q96FJ2,P52565,Q13409 4 |
| Neural crest differentiation 0.28759996620528 0.0951810253365807 0.9241710411427132 1.0 1.0 8 Q9NR77 1 |
| Map3k1 role in promoting and blocking gonadal determination 0.278064052085396 0.0937326955501487 0.925321497311902 1.0 1.0 6 P49841,Q9Y6R4 2 |
| Joubert syndrome 0.3246418544248685 0.0924745145680041 0.9263210388712588 1.0 1.0 19 O75695 1 |
| Nucleotide metabolism 0.3046351257709376 0.0884589111327067 0.929511940436605 1.0 1.0 14 P60891,P00374,P23921,P30520,P31350 5 |
| Head and neck squamous cell carcinoma 0.2871606769856119 0.0777906462297474 0.9379945871294612 1.0 1.0 12 Q00534,P04637,P49815,P62753 4 |
| Mitochondrial complex iii assembly 0.2739876096175571 0.0756718580212655 0.939680165825054 1.0 1.0 9 Q6DKK2,P14927,Q9UDW1,P31930 4 |
| Amino acid metabolism 0.3337814147282167 0.0736716894200743 0.9412716261248768 1.0 1.0 56 P11310,P78540,P08559,Q9NSD9,P54687,P07814,P08243,P52788 8 |
| Complement system in neuronal development and plasticity 0.282558019533771 0.0735389702163239 0.9413772342616132 1.0 1.0 12 O43464,Q7KZI7,Q8N3R9 3 |
| Dna damage response 0.3144538350565802 0.0716477668852159 0.942882225249602 1.0 1.0 24 O14757,Q00534,P14635,Q92878,Q07812,P15927,P04637,Q13535,Q9BXW9,P49959 10 |
| Retinoblastoma gene in cancer 0.3268333864087829 0.0681788662071605 0.9456432501424604 1.0 1.0 49 P23921,Q9UQE7,O00311,P14635,P49642,P04818,P00374,Q14566,O95347,P26358,P33991,Q14683,Q16204,Q14527,Q07864,P15927,P40938,P09429,P31350,P27694,P56282,O14757,Q00534,P35249,P04637,Q9Y619,P26583 27 |
| Photodynamic therapyinduced unfolded protein response 0.2634915665782583 0.0635435101116126 0.9493337131685275 1.0 1.0 10 Q13217 1 |
| Mirna regulation of dna damage response 0.302293580890627 0.062829375688451 0.949902373657163 1.0 1.0 25 O14757,Q00534,P14635,Q92878,Q07812,P15927,P04637,Q13535,Q9BXW9,P49959 10 |
| Ciliopathies 0.2939438460531423 0.0615205345870394 0.9509446611436247 1.0 1.0 22 Q86Y56,O75695 2 |
| Rett syndrome causing genes 0.2790083888782176 0.0613791182959536 0.9510572821848816 1.0 1.0 16 P42858,P46108 2 |
| Pyrimidine metabolism 0.2923168139950897 0.0576180279474871 0.9540528893030256 1.0 1.0 43 P56282,Q9NRF9,P04818,Q9BUI4,Q02127,O15160 6 |
| Atm signaling pathway 0.2741824522649945 0.05704308183443 0.9545108766501416 1.0 1.0 17 O14757,P42575,P14635,Q92878,P04637,Q9BXW9,P49959 7 |
| Egfegfr signaling pathway 0.2454290495611691 0.0533947967390112 0.9574173509015472 1.0 1.0 43 P60953,Q92888,Q16539,Q13464,Q9Y6R4,P46108,P42566,O14964,P53680,Q9Y6I3,P00403,P46934,Q9P0J0 13 |
| Regulation of actin cytoskeleton 0.2616728144709081 0.0517250411076597 0.9587477840252748 1.0 1.0 38 P60953,Q92888,O14974,Q13464,Q8N8S7,P46108,P15311,Q9UQB8,Q14185,O60610,P18206,Q14155,P12814,P26038,O00443 15 |
| Thyroid hormones production and peripheral downstream signaling effects 0.2636197384667453 0.051101646464658 0.9592445240197944 1.0 1.0 18 Q16539,P62753,P49815,P04637,Q9UNY4,P49841,Q7LBC6 7 |
| Focal adhesion 0.2160657520248057 0.0479720209472769 0.9617385409751382 1.0 1.0 35 P60953,O14974,Q13464,Q14315,P46108,Q14185,P17655,O60610,Q9Y490,P18206,Q13418,Q15942,P12814,P49841 14 |
| Metabolic reprogramming in colon cancer 0.1628298367478062 0.0475837385300512 0.9620479921214364 1.0 1.0 35 P08559,Q06203,Q9NQ88,P21912,P48735 5 |
| Dna replication 0.2432179352175487 0.0475101806892306 0.9621066164830344 1.0 1.0 32 P56282,Q7L590,O00311,P49642,Q14566,P15927,P40938,Q9UBD5 8 |
| Parkinubiquitin proteasomal system pathway 0.1868076382363186 0.0464171999716905 0.962977727693298 1.0 1.0 33 Q9UNM6,O00231,P17980,P22314,O43242,Q99460,P43686,Q0VDF9,Q9UNE7,P62195,O75832,P62191,P62333,P34932,O14936 15 |
| Base excision repair 0.2515786616211055 0.0462682597574152 0.9630964372489688 1.0 1.0 20 Q9UBZ4,P56282,Q9NRF9,P29372,P18858,P09429 6 |
| Pathogenic escherichia coli infection 0.2504826941321804 0.0462306082712059 0.9631264466761008 1.0 1.0 19 P60953,Q92747,Q13464,P15311,O15144,P19338 6 |
| Novel intracellular components of rigilike receptor rlr pathway 0.2402005183342719 0.0460718973258476 0.963252944900444 1.0 1.0 13 Q86UT6,Q16539,Q13526,Q3LXA3 4 |
| Acute viral myocarditis 0.2459459691445623 0.0456410508014099 0.9635963494395224 1.0 1.0 17 P42575,P78344,Q04637,Q13418,P49841 5 |
| G13 signaling pathway 0.2436438727994709 0.0453868461000635 0.96379896547521 1.0 1.0 16 P60953,Q92888,Q13464,Q9Y6R4 4 |
| Sterol regulatory elementbinding proteins srebp signaling 0.2203809499025855 0.0452802341801218 0.9638839421161942 1.0 1.0 30 P25490,Q8WTV0 2 |
| Nanoparticle triggered regulated necrosis 0.4208554480174745 0.0451554218045215 0.9639834262264216 1.0 1.0 2 P09874 1 |
| G1 to s cell cycle control 0.2355008833698423 0.0447629492293104 0.9642962577053216 1.0 1.0 27 Q00534,P56282,P49642,Q14566,P15927,P04637,Q9UBD5,Q9Y619 8 |
| Thermogenesis 0.2120738383243298 0.0433723035562503 0.9654047554786724 1.0 1.0 27 P33121,Q16539,P49815,O43772,Q12824,P23786,Q7LBC6 7 |
| Integrated cancer pathway 0.2347531872474088 0.0428198650627075 0.9658451284815984 1.0 1.0 17 O14757,P43246,Q92878,Q07812,P53350,P04637,Q13535,P49959 8 |
| Gastric cancer network 2 0.2312202547951636 0.0426898211735771 0.9659487937007788 1.0 1.0 14 Q9NVI1,Q03252,P40938 3 |
| Mesodermal commitment pathway 0.2285506407937056 0.0423577236054977 0.9662135297562808 1.0 1.0 22 Q12948,Q9UPN3,Q8N3C0,Q13263,O75717,P42858,Q86XI2 7 |
| Tca cycle and deficiency of pyruvate dehydrogenase complex pdhc 0.2300940438871522 0.0421170426430285 0.9664053941607832 1.0 1.0 15 P07954,Q96I99,P09622,P31040,P11498,P08559,O75874,P10515,P53396,P50213,Q02218,P40925,P21399,P36957 14 |
| Interferon type i signaling pathways 0.1997057380419528 0.0376662984515052 0.9699537468580212 1.0 1.0 16 Q16539,P62753,P46108 3 |
| Ccl18 signaling pathway 0.183030263849034 0.0339638228501623 0.9729059992301046 1.0 1.0 8 P00403 1 |
|
|
